Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (5y) (2015 - 2025)
Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-15.14% |
| Dec 31, 2024 |
-46.82% |
| Dec 31, 2022 |
6.61% |
| Sep 30, 2022 |
27.54% |
| Jun 30, 2022 |
-35.52% |
| Mar 31, 2022 |
40.44% |
| Dec 31, 2021 |
-40.63% |
| Sep 30, 2021 |
-7.57% |
| Jun 30, 2021 |
12.59% |
| Mar 31, 2021 |
-26.05% |
| Dec 31, 2020 |
30.34% |
| Sep 30, 2020 |
-8.68% |
| Jun 30, 2020 |
-21.08% |
| Mar 31, 2020 |
80.14% |
| Dec 31, 2019 |
25.03% |
| Sep 30, 2019 |
60.95% |
| Jun 30, 2019 |
8.92% |
| Mar 31, 2019 |
16.19% |
| Dec 31, 2018 |
-16.30% |
| Sep 30, 2018 |
4.04% |
